Medical Affairs Department
Field-based role
As a Medical Scientific Liaison (MSL), you will bring scientific evidence in diabetes, obesity and other cardiometabolic diseases to the healthcare professionals who rely on it every day. We are filling two positions in Santiago, each with a distinct focus: one will expand engagement with non-traditional opinion leaders and healthcare professionals through digital and emerging channels, while the other will strengthen our established field MSL model. Across both roles, we are looking for people who can adapt and innovate in scientific dialogue, embracing new models of leadership and engagement to help clinicians make well-informed decisions for people living with serious chronic diseases.
You are a healthcare professional who turns evidence into clear conversations. You will need:
Your time will be split between field engagement and building capabilities inside the company. You will also manage regional medical education activities.
You will join the Medical Affairs team in Chile, where colleagues connect commercial strategy, medical affairs and business development across therapy areas. The team designs and delivers the scientific communication strategy, builds relationships with opinion leaders, provides medical education to healthcare professionals and gives internal medical guidance through training and communication.
You will be trusted to own your work in the field and to make your voice heard on how the team engages the healthcare community. As a medical professional, you will deepen your therapeutic expertise and build new skills through global training. You will also gain practical experience across field work, medical education and internal capability-building. If you hold the digitally focused position, you will help shape new channels and ways of working.
The work moves at pace and we keep standards high. Patient safety, ethics and quality are never compromised, and we expect you to act with clarity and urgency within them.
If you are ready, apply for the role by 15 October 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We run an inclusive recruitment process and offer equal opportunity to all applicants. At Novo, we know it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world, and that is only possible with talented employees who bring diverse perspectives, backgrounds and cultures. That is why we work to build an inclusive culture that celebrates the diversity of our employees, the people we serve and the communities we operate in.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html